Temozolomide after radiotherapy improves glioma survival

Oncology for children: what can be done when resources are scarce?

Relapsed Hodgkin lymphoma in PET positive patients

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Understanding personalised medicine - the e-learning course

Inflammatory microenvironment regulates colorectal cancer progression

Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors

Chronic lymphocytic leukaemia: Transition to a new era

The role of the microenvironment and novel therapies in CLL

Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions

Frontline therapy in young patients with myeloma

MINDACT breast cancer clinical trial: First results and impact on future trial design